Compound to treat Sjogren's Syndrome
US11723979B2 · kind B2 · utility
0Cited by
4References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 25, 2020 |
| Grant date | Aug 15, 2023 |
| Priority date | — |
| Expiry date | Jul 31, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes compositions and methods for providing a therapeutically acceptable dose of an active pharmaceutical agent for once a day delivery of the active pharmaceutical compound in an amount effective to treat at least one of: Sjogren's syndrome, Xerostomia, dry mouth, hypo-salivation, or dental carries due to reduced or compromised salivation, wherein both the peak and trough times in the blood level at 8 hours is greater than 25% of the peak value in the blood level concentration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.